Pharmaceutical Supply – DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES

The contract solicits the supply of FDA-compliant diphenhydramine hydrochloride capsules, each containing 50mg of active ingredient, packaged in quantities of 100 capsules per bottle. All products must meet stringent military-compliant packaging, labeling, and documentation requirements as specified by the Defense Logistics Agency and United States Pharmacopeia standards to ensure consistency, safety, and traceability for federal use. The drug substance must adhere to current Good Manufacturing Practices and FDA regulations to guarantee quality and efficacy throughout the supply chain. The solicitation falls under NAICS code 325412 for pharmaceutical preparation manufacturing and is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. Performance is designated for Fort Stewart, Georgia, with a response deadline of July 21, 2026. The contract is structured as a subcontract and does not specify any set-aside provisions. Potential suppliers must ensure full compliance with all technical, regulatory, and logistical specifications to be considered for award, with no flexibility permitted in packaging, labeling, or documentation formats governed by military protocols.